Proteome Sciences plc (the "Company") Appointment of Nominated Adviser and Broker

The Board is pleased to announce that finnCap has been appointed as Nominated Adviser and sole

Broker to the Company with immediate effect.

- Ends -

For further information please contact: Proteome Sciences plc

Christopher Pearce, Executive Chairman
Dr. Ian Pike, Chief Operating Officer Tel: +44 (0)1932 865065
Geoff Ellis, Finance Director

finnCap Limited (nominated adviser & broker)

Geoff Nash/James Thompson Tel : +44 (0)20 7220 0500

Public Relations

IKON Associates Email: adrian@ikonassociates.com
Adrian Shaw Tel: +44 (0)1483 271291
Mobile +44(0)7979 900733

Notes for editors: About Proteome Sciences plc (www.proteomics.com)

Proteome Sciences is a global leader in applied proteomics and peptidomics offering high
sensitivity, proprietary technologies for protein and peptide biomarker discovery, validation and assay development. The Company is headquartered in Cobham, UK, with laboratory facilities in London and Frankfurt.
Proteome Sciences' proprietary research has discovered a large number of novel protein biomarkers in key human diseases and is focused mainly in neurological/neurodegenerative conditions and in cancer. It has discovered and patented blood biomarkers in Alzheimer's disease, stroke, brain damage and lung cancer for diagnostic and treatment applications that are available for license or have already been outlicensed.
The Company's PS Biomarker Services™ division provides outsourced proteomics services and proprietary biomarker assays to pharmaceutical, biotechnology and diagnostics companies from its ISO 9001: 2008 facility in Frankfurt, Germany.

distributed by